Pulmonx Corp. (LUNG)
2.02
+0.07
(+3.59%)
USD |
NASDAQ |
Jan 14, 14:23
Pulmonx Research and Development Expense (Quarterly): 4.846M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| IRIDEX Corp. | 0.972M |
| Stereotaxis, Inc. | 2.546M |
| Electromed, Inc. | 0.241M |
| Axogen, Inc. | 7.565M |
| Myomo, Inc. | 1.528M |